Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Mutares in connection with the acquisition of Allianceplus Sweden
Mandate

Vinge advises Mutares in connection with the acquisition of Allianceplus Sweden

November 09, 2021 Employment and Benefits M&A EU, Competition and Regulatory

Vinge advises the German private equity firm Mutares SE & Co. KGaA in connection with the acquisition of Allianceplus Sweden (“Allianceplus”) from Allianceplus Holding A/S, a portfolio company of Polaris Private Equity.

Allianceplus is engaged in the business of soft facility management. The company is headquartered in Stockholm and offers its services across Sweden with primary focus on Stockholm, Gothenburg, and Malmö. Allianceplus generated approx. EUR 27 million and employed over 500 people in 2020.

Mutares SE & Co. KGaA, a listed private equity holding company with offices in Munich (HQ), Frankfurt, London, Madrid, Milan, Paris, Stockholm and Vienna, acquires small- and medium-sized companies and parts of groups in special situations with headquarters in Europe that show significant potential for operational improvement and are sold again after undergoing a repositioning and stabilization process.

Vinge’s team consisted of Karl Klackenberg and Christina Kokko (M&A), Lisa Hörnqvist (Commercial agreements), Ebba Svenburg (Employment) together with Sebastian Örndahl and Jesper Ekman (Merger filing).

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025